Leading the worldwide fight to treat and cure
Tay-Sachs, Canavan, GM1 and Sandhoff diseases

NTSAD Virtual Family Conference | 2021 GM2 Sandhoff and Tay-Sachs Breakout

Details

Ruben Giorgino, Head of Clinical Research and Development
Azafaros drug development program


Joel Ellis, PhD, Director of Toxicology
Recursion Pharmaceuticals drug development program


Suyash Prasad, MBBS, MSc, Chief Medical Officer & Head of R&D
Taysha gene therapies clinical trial


Erika De Boever, VP Clinical Development
Sio Gene Therapies clinical trial

Virtual Conference

View the NTSAD Annual Family Conference Research Exhibit Hall

Please contact Becky Benson, Conference and Family Services Coordinator here with any questions or concerns that are conference related.

2021 Conference Sponsors

COURAGE
Sanofi Genzyme
HOPE
Aspa Therapeutics
Recursion
Laura and Simeon Schindelman
Taysha Gene Therapies 
INSPIRATION
Drive FORE Dylan
Lysogene
Mathew Forbes Romer Foundation
Passage Bio 
Quinn Madeleine Foundation
Sio Gene Therapies  
DETERMINATION
Amicus Therapeutics 
Azafaros B.V.
Cameron & Hayden Lord Foundation
Gain Therapeutics 
Idorsia Pharmaceuticals, Ltd. 
COMMUNITY
B Brave Foundation
Bonnie and Barry Davis in loving memory of Adam Davis 
The Evan Lee Ungerleider Fund
IntraBio 
National Tay-Sachs & Allied Diseases Association of Delaware Valley
NTSAD New York Area Fund 
*sponsors as of 4/15/21

Login